Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macrolides for KCNJ5-Mutated Aldosterone-Producing Adenoma
NCT03414918Unknown
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Mar 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of clarithromycin and roxithromycin in primary aldosteronism (PA) (2 arms), sponsored by Azienda Ospedaliero-Universitaria di Padova. Primary endpoints: Change in Relative Aldosterone Secretion Index and Change in plasma aldosterone concentration. Status: unknown.
02
Drugs
clarithromycinroxithromycin
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT03414918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03414918.